Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
5.90
-0.21 (-3.47%)
Mar 31, 2025, 3:57 PM EDT - Market open

Journey Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Operating Revenue
55.1359.667163.1344.53
Upgrade
Other Revenue
119.522.67--
Upgrade
Revenue
56.1379.1873.6763.1344.53
Upgrade
Revenue Growth (YoY)
-29.11%7.48%16.69%41.77%27.52%
Upgrade
Cost of Revenue
20.8822.8930.7825.5814.59
Upgrade
Gross Profit
35.2656.2942.8937.5529.94
Upgrade
Selling, General & Admin
40.243.9159.4739.8322.09
Upgrade
Research & Development
9.867.5410.9416.56-
Upgrade
Other Operating Expenses
-4.55----
Upgrade
Operating Expenses
48.9355.2270.4156.3922.09
Upgrade
Operating Income
-13.681.07-27.52-18.847.85
Upgrade
Interest Expense
-2.7-1.7-2.02-7.03-0.7
Upgrade
Interest & Investment Income
0.760.320.060-
Upgrade
Currency Exchange Gain (Loss)
-0.12-0.18-0.09--
Upgrade
Other Non Operating Income (Expenses)
----0.45-
Upgrade
EBT Excluding Unusual Items
-15.74-0.49-29.57-26.327.15
Upgrade
Merger & Restructuring Charges
----6.5-
Upgrade
Asset Writedown
--3.14---
Upgrade
Other Unusual Items
1.13---9.54-
Upgrade
Pretax Income
-14.61-3.63-29.57-42.367.15
Upgrade
Income Tax Expense
0.060.220.061.631.87
Upgrade
Net Income
-14.67-3.85-29.63-43.995.28
Upgrade
Net Income to Common
-14.67-3.85-29.63-43.995.28
Upgrade
Net Income Growth
----45.74%
Upgrade
Shares Outstanding (Basic)
201818109
Upgrade
Shares Outstanding (Diluted)
2018181011
Upgrade
Shares Change (YoY)
12.06%4.00%72.05%-5.96%7.55%
Upgrade
EPS (Basic)
-0.72-0.21-1.69-4.320.58
Upgrade
EPS (Diluted)
-0.72-0.21-1.69-4.320.49
Upgrade
EPS Growth
----36.11%
Upgrade
Free Cash Flow
-9.135.24-13.53-2.185.13
Upgrade
Free Cash Flow Per Share
-0.450.29-0.77-0.210.47
Upgrade
Gross Margin
62.80%71.09%58.23%59.48%67.23%
Upgrade
Operating Margin
-24.37%1.35%-37.35%-29.84%17.63%
Upgrade
Profit Margin
-26.14%-4.87%-40.22%-69.68%11.86%
Upgrade
Free Cash Flow Margin
-16.26%6.62%-18.37%-3.45%11.53%
Upgrade
EBITDA
-10.254.84-23.24-16.379.28
Upgrade
EBITDA Margin
-18.27%6.11%-31.55%-25.92%20.83%
Upgrade
D&A For EBITDA
3.423.774.282.471.43
Upgrade
EBIT
-13.681.07-27.52-18.847.85
Upgrade
EBIT Margin
-24.37%1.35%-37.35%-29.84%17.63%
Upgrade
Effective Tax Rate
----26.14%
Upgrade
Revenue as Reported
56.1379.1873.6763.13-
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q